| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |